Biomeme
Philadelphia, US · Founded 2012 · Delaware corporation · 64 employees on LinkedIn · 4 known investors
Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
Founders & leadership
Biomeme was founded in 2012 by Max Perelman, Marc DeJong, and Jesse vanWestrienen.
MD
Marc DeJongCo-founder
CW
Chris WoodsChief Medical Officer
MD
Marc DeJohnNamed on SEC filing
JV
Jesse van WestrienenNamed on SEC filing
KS
Kristy StoudtDirector of Regulatory Affairs
RS
Raphael ShapiroDirector of Engineering
NS
Nate ShapiroDirector of Medical Strategy
TB
Tiffany BrattonCLIA Laboratory Director
Investors · 4
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 2 rounds · 2014–2017
▶$4.5MraisedMay 2017 · 35 investors · Other Health CareRule 506(b)
▶$4.5MraisedMay 2017 · 35 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Max PerelmanExecutive Officer, Director
- Marc DeJongExecutive Officer, Director
- Jesse vanWestrienenExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $4.5M
- Minimum investment
- $10K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$992.8KraisedJan 2014 · 19 investors · Other Health CareRule 506(c)
▶$992.8KraisedJan 2014 · 19 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Marc DeJohnExecutive Officer, Director
- Max PerelmanExecutive Officer, Director
- Jesse van WestrienenExecutive Officer, Director
- Offering amount
- $1.9M
- Amount sold
- $992.8K
- Minimum investment
- $10K
- Sales commissions
- $17.5K
- Placement agents
- Microventure Marketplace Inc.
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapLabcorp92 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Osfhealthcare77 shared keywordsOSF HealthCare is a health care provider operating hospitals and clinics across Illinois and Michigan, offering services including cancer treatments such as proton therapy and brachytherapy, digital health through OSF OnCall, and clinical research. It also runs OSF Innovation and provides patient tools like the My OSF mobile app and OSF MyChart.
Companies competing with Biomeme for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Biomeme do?
- Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
- Who founded Biomeme?
- Biomeme was founded by Max Perelman, Marc DeJong, Jesse vanWestrienen in 2012.
- Who are Biomeme's investors?
- Biomeme's investors include Darco Capital, NextFab Ventures, Robin Hood Ventures, MicroVentures.
- How much funding has Biomeme raised?
- Biomeme has disclosed $5.5M raised across 2 rounds.
- Where is Biomeme headquartered?
- Biomeme is headquartered in Philadelphia, US.